208 related articles for article (PubMed ID: 8895507)
21. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J
Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658
[TBL] [Abstract][Full Text] [Related]
22. Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression.
Albertazzi E; Cajone F; Leone BE; Naguib RN; Lakshmi MS; Sherbet GV
DNA Cell Biol; 1998 Apr; 17(4):335-42. PubMed ID: 9570150
[TBL] [Abstract][Full Text] [Related]
23. Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene.
Mangues R; Seidman I; Pellicer A; Gordon JW
Oncogene; 1990 Oct; 5(10):1491-7. PubMed ID: 2174525
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.
Quan L; Dittmar A; Zhou Y; Hutson A; Stassen AP; Demant P
Genes Chromosomes Cancer; 2012 Jul; 51(7):631-43. PubMed ID: 22419448
[TBL] [Abstract][Full Text] [Related]
25. [Mts1 protein in the cytoplasm of metastasizing tumors].
Kriazhevskaia MV; Vorovch MF; Georgiev GP; Lukanidin EM
Dokl Akad Nauk; 1995 May; 342(2):259-61. PubMed ID: 7633352
[No Abstract] [Full Text] [Related]
26. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
27. Genetically modified mouse models to study the role of metastasis-promoting S100A4(mts1) protein in metastatic mammary cancer.
Ambartsumian N; Grigorian M; Lukanidin E
J Dairy Res; 2005; 72 Spec No():27-33. PubMed ID: 16180718
[TBL] [Abstract][Full Text] [Related]
28. Characterization of two splice variants of metastasis-associated human mts1 gene.
Ambartsumian N; Tarabykina S; Grigorian M; Tulchinsky E; Hulgaard E; Georgiev G; Lukanidin E
Gene; 1995 Jun; 159(1):125-30. PubMed ID: 7607566
[TBL] [Abstract][Full Text] [Related]
29. Establishment and characterization of immortalized non-transplantable mouse mammary cell lines cloned from a MMTV-induced tumor cell line cultured for a long duration.
Takenaka T; Saga S; Miyaishi O; Imai M; Yokoi T; Lu J; Wajjwalku W; Kusakabe M; Taguchi O; Matsuyama M
Nagoya J Med Sci; 1991 Mar; 53(1-4):9-21. PubMed ID: 1666666
[TBL] [Abstract][Full Text] [Related]
30. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10578-82. PubMed ID: 1359541
[TBL] [Abstract][Full Text] [Related]
31. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
White DE; Cardiff RD; Dedhar S; Muller WJ
Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
[TBL] [Abstract][Full Text] [Related]
32. Correlation between the detection of specific mouse mammary tumor proviral sequences and the presence of pulmonary metastases in mice bearing spontaneous mammary tumors.
Drohan W; Cardiff RD; Lund JK; Schlom J
Cancer Res; 1980 Jul; 40(7):2316-22. PubMed ID: 6248203
[TBL] [Abstract][Full Text] [Related]
33. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer.
Li Y; Hively WP; Varmus HE
Oncogene; 2000 Feb; 19(8):1002-9. PubMed ID: 10713683
[TBL] [Abstract][Full Text] [Related]
34. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways.
Callahan R; Smith GH
Oncogene; 2000 Feb; 19(8):992-1001. PubMed ID: 10713682
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
36. Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue.
Tennant RW; Rao GN; Russfield A; Seilkop S; Braun AG
Carcinogenesis; 1993 Jan; 14(1):29-35. PubMed ID: 8093862
[TBL] [Abstract][Full Text] [Related]
37. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model.
Clausse N; Baines D; Moore R; Brookes S; Dickson C; Peters G
Virology; 1993 May; 194(1):157-65. PubMed ID: 8386870
[TBL] [Abstract][Full Text] [Related]
38. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line.
Ford HL; Salim MM; Chakravarty R; Aluiddin V; Zain SB
Oncogene; 1995 Nov; 11(10):2067-75. PubMed ID: 7478526
[TBL] [Abstract][Full Text] [Related]
39. The mts1 gene and control of tumor metastasis.
Grigorian MS; Tulchinsky EM; Zain S; Ebralidze AK; Kramerov DA; Kriajevska MV; Georgiev GP; Lukanidin EM
Gene; 1993 Dec; 135(1-2):229-38. PubMed ID: 8276262
[TBL] [Abstract][Full Text] [Related]
40. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis.
Xue C; Plieth D; Venkov C; Xu C; Neilson EG
Cancer Res; 2003 Jun; 63(12):3386-94. PubMed ID: 12810675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
